Molecule Details
| InChIKey | DPWPWRLQFGFJFI-UHFFFAOYSA-N |
|---|---|
| Compound Name | Pargyline |
| Canonical SMILES | C#CCN(C)Cc1ccccc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.42 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB01626 |
|---|---|
| Drug Name | Pargyline |
| CAS Number | 555-57-7 |
| Groups | approved |
| ATC Codes | C02LL01 C02KC01 |
| Description | Pargyline is a monoamine oxidase inhibitor with antihypertensive properties. |
Categories: Agents that produce hypertension Agents that reduce seizure threshold Amines Antidepressive Agents Antihypertensive Agents Benzene Derivatives Benzyl Compounds Benzylamines Cardiovascular Agents Central Nervous System Depressants Enzyme Inhibitors MAO Inhibitors and Diuretics Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates Monoamine Oxidase Inhibitors Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
Cross-references: BindingDB: 50172756 ChEBI: 7930 CHEMBL673 ChemSpider: 4526 C07414 D08453 PharmGKB: PA450797 PubChem:4688 PubChem:46507368 RxCUI: 7930 Therapeutic Targets Database: DAP000580 Wikipedia: Pargyline ZINC: ZINC000053084618